Rx (Prescription Medicine)
Pazoci 200毫克片剂用于治疗晚期肾癌和软组织肉瘤。请遵医嘱服用本药物，以有效控制病情。
Pazoci 200毫克片剂是一种含有帕唑帕尼（Pazopanib）作为活性成分的药物。帕唑帕尼是一种酪氨酸激酶抑制剂，用于治疗晚期肾细胞癌（肾癌）和晚期软组织肉瘤。它通过阻断参与癌细胞生长和扩散的某些蛋白质的活性来发挥作用。Pazoci 200毫克片剂以片剂形式口服给药。严格按照您的医疗保健提供者的处方服用本药物至关重要。请勿压碎或咀嚼片剂。重要的注意事项包括告知医生您已有的任何疾病，特别是肝脏问题、心脏问题或高血压，以及您正在服用的任何其他药物。请遵医嘱定期监测肝功能和血压。将Pazoci 200毫克片剂储存在室温下，远离潮湿和高温，并放在儿童接触不到的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength |
其他品牌的 Pazopanib 200 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
